Company / R&D Expense
Scholar Rock Holding Corp R&D Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$208.4M
FY2025
5-year range
$108.5M / $208.4M
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#80 of 210
Health Care
What the data says
At $208M, Scholar Rock Holding Corp's r&d expense ranks #80 of 210 in the Health Care sector. Improved from $122M to $208M over the past 2 years.
Based on SEC 10-K filings.
$208M in FY2025 with a 5-year CAGR of +23.0%.
Improved from $122M to $208M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +23.0%
- 10-Year CAGR
- -
Sector benchmark
#80 of 210 in Health CareTop 38% of 210This company $208.4M Sector average $644.1M
▼
-67.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.0%, indicating consistent growth.
- In FY2025, r&d expense increased 12.9% year-over-year.
- Ranks #80 out of 210 companies in the Health Care sector.
- Lowest r&d expense in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.4M | +12.9% |
| FY2024 | $184.6M | +51.4% |
| FY2023 | $121.9M | -2.0% |
| FY2022 | $124.4M | +14.7% |
| FY2021 | $108.5M | +46.5% |
| FY2020 | $74.1M | +104.0% |
| FY2019 | $36.3M | +82.1% |
| FY2018 | $19.9M | +0.0% |
| FY2017 | $19.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026